Bluejay Diagnostics director buys 12,500 shares at $2
Bluejay Diagnostics director Wurth Douglas Clark bought additional common stock in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Bluejay Diagnostics director Wurth Douglas Clark bought additional common stock in the company. On March 14, 2026, he purchased 12,500 shares of Bluejay Diagnostics, Inc. common stock from the issuer in a private placement at $2.00 per share.
Following this transaction, his reported holdings increased to 12,608 shares of common stock, which includes 34 shares held by Wurth Holdings LLC, an entity he controls.
Insider Trade Summary
Net Buyer: 12,500 shares
Net Buy
1 txn
Insider
Wurth Douglas Clark
Role
Director
Bought
12,500 shs ($25K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 12,500 | $2.00 | $25K |
Holdings After Transaction:
Common Stock — 12,608 shares (Direct)
Footnotes (2)
- F1. On March 14, 2026, Mr. Wurth purchased 12,500 shares of the issuer's common stock ("Common Stock") from the issuer in a private placement at a price of $2.00 per share.
- F2. Of such amount, 34 shares of Common Stock are held by Wurth Holdings LLC, an entity controlled by Mr. Wurth.
Key Figures
Shares purchased: 12,500 shares
Purchase price: $2.00 per share
Total holdings after trade: 12,608 shares
+1 more
4 metrics
Shares purchased
12,500 shares
Common Stock bought on March 14, 2026
Purchase price
$2.00 per share
Private placement price with issuer
Total holdings after trade
12,608 shares
Common Stock position following transaction
Indirect holdings via LLC
34 shares
Held by Wurth Holdings LLC, controlled by Mr. Wurth
Key Terms
private placement, Common Stock, open-market purchase, Form 4
4 terms
private placement financial
"purchased 12,500 shares of the issuer's common stock ... in a private placement at a price of $2.00 per share"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Common Stock financial
"shares of the issuer's common stock ("Common Stock") from the issuer in a private placement"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Bluejay Diagnostics (BJDX) report for Wurth Douglas Clark?
Bluejay Diagnostics reported that director Wurth Douglas Clark purchased 12,500 shares of common stock. The shares were bought from the company in a private placement at $2.00 per share, increasing his total reported holdings to 12,608 shares of BJDX common stock.
Was the Bluejay Diagnostics (BJDX) insider transaction an open-market purchase?
Although coded as a purchase, the Form 4 footnote clarifies it was a private placement. On March 14, 2026, Wurth Douglas Clark bought 12,500 BJDX common shares directly from the issuer at $2.00 per share, rather than on the open market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates